Real-world data of the use and experience of caplacizumab for the treatment of acquired thrombotic thrombocytopenic purpura: Case series.
Transfus Apher Sci
; 62(3): 103722, 2023 Jun.
Article
in En
| MEDLINE
| ID: mdl-37169697
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Purpura, Thrombotic Thrombocytopenic
Type of study:
Observational_studies
Limits:
Humans
Language:
En
Journal:
Transfus Apher Sci
Journal subject:
HEMATOLOGIA
Year:
2023
Type:
Article
Affiliation country:
Spain